Search research articles
Contact Us
Filters
Showing results (91-100 of 156) with videos related to
Page
of 16
Sort By:
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
May 10, 2005
[X-linked adrenoleukodystrophy in a female proband: clinical presentation, biological diagnosis and family consequences]
G Lesca, M T Vanier, E Creisson, et al.
Journal of Inherited Metabolic Disease
|
January 1, 1994
A family with visceral course of Niemann-Pick disease, macular halo syndrome and low sphingomyelin degradation rate
W Sperl, G Bart, M T Vanier, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 18, 2006
Niemann-Pick type C disease in a 68-year-old patient
G Trendelenburg, M T Vanier, S Maza, et al.
Lancet (London, England)
|
May 6, 1989
Diagnosis of Niemann-Pick disease type C on chorionic villus cells
M T Vanier, R M Rousson, G Mandon, et al.
Clinical Genetics
|
January 1, 1985
Biochemical studies in Niemann-Pick disease. III. In vitro and in vivo assays of sphingomyelin degradation in cultured skin fibroblasts and amniotic fluid cells for the diagnosis of the various forms of the disease
M T Vanier, R Rousson, I Garcia, et al.
Neuroscience Letters
|
April 29, 1983
Effect of tricyclic antidepressants on sphingomyelinase and other sphingolipid hydrolases in C6 cultured glioma cells
S Albouz, M T Vanier, J J Hauw, et al.
Pediatrie
|
September 1, 1977
[Krabbe's disease]
L Larget-Piet, M T Vanier, J Berthelot, et al.
Clinical Genetics
|
May 1, 1988
Niemann-Pick disease group C: clinical variability and diagnosis based on defective cholesterol esterification. A collaborative study on 70 patients
M T Vanier, D A Wenger, M E Comly, et al.
Journal of Neuroscience Research
|
January 29, 2000
Biochemistry and neuropathology of mice doubly deficient in synthesis and degradation of galactosylceramide
T Ezoe, M T Vanier, Y Oya, et al.
Journal of Neuroscience Research
|
January 29, 2000
Twitcher mice with only a single active galactosylceramide synthase gene exhibit clearly detectable but therapeutically minor phenotypic improvements
T Ezoe, M T Vanier, Y Oya, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 156) with videos related to
Sort By:
Page
of 16
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
May 10, 2005
[X-linked adrenoleukodystrophy in a female proband: clinical presentation, biological diagnosis and family consequences]
G Lesca, M T Vanier, E Creisson, et al.
Journal of Inherited Metabolic Disease
|
January 1, 1994
A family with visceral course of Niemann-Pick disease, macular halo syndrome and low sphingomyelin degradation rate
W Sperl, G Bart, M T Vanier, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 18, 2006
Niemann-Pick type C disease in a 68-year-old patient
G Trendelenburg, M T Vanier, S Maza, et al.
Lancet (London, England)
|
May 6, 1989
Diagnosis of Niemann-Pick disease type C on chorionic villus cells
M T Vanier, R M Rousson, G Mandon, et al.
Clinical Genetics
|
January 1, 1985
Biochemical studies in Niemann-Pick disease. III. In vitro and in vivo assays of sphingomyelin degradation in cultured skin fibroblasts and amniotic fluid cells for the diagnosis of the various forms of the disease
M T Vanier, R Rousson, I Garcia, et al.
Neuroscience Letters
|
April 29, 1983
Effect of tricyclic antidepressants on sphingomyelinase and other sphingolipid hydrolases in C6 cultured glioma cells
S Albouz, M T Vanier, J J Hauw, et al.
Pediatrie
|
September 1, 1977
[Krabbe's disease]
L Larget-Piet, M T Vanier, J Berthelot, et al.
Clinical Genetics
|
May 1, 1988
Niemann-Pick disease group C: clinical variability and diagnosis based on defective cholesterol esterification. A collaborative study on 70 patients
M T Vanier, D A Wenger, M E Comly, et al.
Journal of Neuroscience Research
|
January 29, 2000
Biochemistry and neuropathology of mice doubly deficient in synthesis and degradation of galactosylceramide
T Ezoe, M T Vanier, Y Oya, et al.
Journal of Neuroscience Research
|
January 29, 2000
Twitcher mice with only a single active galactosylceramide synthase gene exhibit clearly detectable but therapeutically minor phenotypic improvements
T Ezoe, M T Vanier, Y Oya, et al.
Page
of 16